Literature DB >> 26282408

Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains.

Myung-Jin Choi1, Kwan Soo Ko2.   

Abstract

In this study, we investigated the effects of colistin resistance on virulence and fitness in hypermucoviscous (HV) Klebsiella pneumoniae sequence type 23 (ST23) strains. Colistin-resistant mutants were developed from three colistin-susceptible HV K. pneumoniae ST23 strains. The lipid A structures of strains were analyzed by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry. Changes in HV were investigated using the string test, and extracellular polysaccharide production was quantified. The expression levels of the phoQ, pmrD, pmrB, pbgP, magA, and p-rmpA2 genes, serum resistance, and biofilm-forming activity were determined. The fitness of colistin-resistant mutants compared to that of the parental strains was examined by determining the competitive index (CI). The colistin-resistant mutants exhibited reduced HV, which was accompanied by decreased formation of capsular polysaccharides (CPS) and reduced expression of genes (magA and p-rmpA2). While there was enhanced expression of pmrD and pbgP in all colistin-resistant derivatives, there were differences in the expression levels of phoQ and pmrB between strains. MALDI-TOF analysis detected the addition of aminoarabinose or palmitate to the lipid A moiety of lipopolysaccharide in the colistin-resistant derivatives. In addition, survival rates in the presence of normal human serum were decreased in the mutant strains, and CI values (0.01 to 0.19) indicated significant fitness defects in the colistin-resistant derivatives compared to the respective parental strains. In hypervirulent HV K. pneumoniae strains, the acquisition of colistin resistance was accompanied by reduced CPS production, impaired virulence, and a significant fitness cost.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26282408      PMCID: PMC4604379          DOI: 10.1128/AAC.00952-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression.

Authors:  R A Edwards; L H Keller; D M Schifferli
Journal:  Gene       Date:  1998-01-30       Impact factor: 3.688

2.  In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment.

Authors:  Antonio Cannatelli; Vincenzo Di Pilato; Tommaso Giani; Fabio Arena; Simone Ambretti; Paolo Gaibani; Marco Maria D'Andrea; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

3.  RmpA regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae CG43.

Authors:  H Y Cheng; Y S Chen; C Y Wu; H Y Chang; Y C Lai; H L Peng
Journal:  J Bacteriol       Date:  2010-04-09       Impact factor: 3.490

4.  KpnEF, a new member of the Klebsiella pneumoniae cell envelope stress response regulon, is an SMR-type efflux pump involved in broad-spectrum antimicrobial resistance.

Authors:  Vijaya Bharathi Srinivasan; Govindan Rajamohan
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

Review 5.  Colistin resistance in Klebsiella pneumoniae.

Authors:  Young-Mi Ah; Ah-Jung Kim; Ju-Yeun Lee
Journal:  Int J Antimicrob Agents       Date:  2014-04-12       Impact factor: 5.283

6.  Molecular typing and virulence analysis of serotype K1 Klebsiella pneumoniae strains isolated from liver abscess patients and stool samples from noninfectious subjects in Hong Kong, Singapore, and Taiwan.

Authors:  L Kristopher Siu; Chang-Phone Fung; Feng-Yee Chang; Nelson Lee; Kuo-Ming Yeh; Tse Hsien Koh; Margaret Ip
Journal:  J Clin Microbiol       Date:  2011-09-07       Impact factor: 5.948

7.  Klebsiella pneumoniae K1 liver abscess and septic endophthalmitis in a U.S. resident.

Authors:  Darpun D Sachdev; Michael T Yin; Jason D Horowitz; Sri Krishna Mukkamala; Song Eun Lee; Adam J Ratner
Journal:  J Clin Microbiol       Date:  2013-01-09       Impact factor: 5.948

8.  Appearance of Klebsiella pneumoniae liver abscess syndrome in Argentina: case report and review of molecular mechanisms of pathogenesis.

Authors:  Andrea Vila; Andrea Cassata; Hugo Pagella; Claudio Amadio; Kuo-Ming Yeh; Feng-Yee Chang; L Kristopher Siu
Journal:  Open Microbiol J       Date:  2011-09-27

9.  Emerging K1 serotype Klebsiella pneumoniae primary liver abscess: three cases presenting to a single university hospital in Norway.

Authors:  Kristoffer Holmås; Aasmund Fostervold; Steen Gustav Stahlhut; Carsten Struve; Jan Cato Holter
Journal:  Clin Case Rep       Date:  2014-05-25

10.  Role of capsule and O antigen in the virulence of uropathogenic Escherichia coli.

Authors:  Sohinee Sarkar; Glen C Ulett; Makrina Totsika; Minh-Duy Phan; Mark A Schembri
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more
  30 in total

1.  Rapid and Consistent Evolution of Colistin Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa during Morbidostat Culture.

Authors:  Bianca Dößelmann; Matthias Willmann; Matthias Steglich; Boyke Bunk; Ulrich Nübel; Silke Peter; Richard A Neher
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  The contribution of capsule polysaccharide genes to virulence of Klebsiella pneumoniae.

Authors:  Kwan Soo Ko
Journal:  Virulence       Date:  2016-10-07       Impact factor: 5.882

3.  Deciphering Heteroresistance to Colistin in a Klebsiella pneumoniae Isolate from Marseille, France.

Authors:  Lucie Bardet; Sophie Baron; Thongpan Leangapichart; Liliane Okdah; Seydina M Diene; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

4.  Mechanisms of Increased Resistance to Chlorhexidine and Cross-Resistance to Colistin following Exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine.

Authors:  Matthew E Wand; Lucy J Bock; Laura C Bonney; J Mark Sutton
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

5.  Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate.

Authors:  Miranda E Pitt; Minh Duc Cao; Mark S Butler; Soumya Ramu; Devika Ganesamoorthy; Mark A T Blaskovich; Lachlan J M Coin; Matthew A Cooper
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

Review 6.  Correlation between antimicrobial resistance and virulence in Klebsiella pneumoniae.

Authors:  C Hennequin; F Robin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-30       Impact factor: 3.267

Review 7.  Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Angela Gomez-Simmonds; Anne-Catrin Uhlemann
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

8.  Comparison of virulence between matt and mucoid colonies of Klebsiella pneumoniae coproducing NDM-1 and OXA-232 isolated from a single patient.

Authors:  Haejeong Lee; Jin Yang Baek; So Yeon Kim; HyunJi Jo; KyeongJin Kang; Jae-Hoon Ko; Sun Young Cho; Doo Ryeon Chung; Kyong Ran Peck; Jae-Hoon Song; Kwan Soo Ko
Journal:  J Microbiol       Date:  2018-08-23       Impact factor: 3.422

Review 9.  Pseudomonas aeruginosa and Klebsiella pneumoniae Adaptation to Innate Immune Clearance Mechanisms in the Lung.

Authors:  Sebastian A Riquelme; Danielle Ahn; Alice Prince
Journal:  J Innate Immun       Date:  2018-04-04       Impact factor: 7.349

10.  Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.

Authors:  Ji-Young Lee; Myung-Jin Choi; Hyeon Jin Choi; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.